Form 4 for MGNX MACROGENICS INC
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-15 · accession 0001125345-24-000043 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-20 | 2024-02-15 | MGNX | Eck Stephen L. | Chief Medical Off | F - Tax | $17.40 | -6,872 | 9,798 | -41% | -$119.6K |
| D | 2024-02-20 | 2024-02-15 | MGNX | Eck Stephen L. | Chief Medical Off | M - OptEx | $0.00 | +16.7K | 16.7K | New | $0 |
| D | 2024-02-20 | 2024-02-15 | MGNX | Eck Stephen L. | Chief Medical Off | M - OptEx | $0.00 | -16.7K | 33.3K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-15 | F | D | 6,872 | $17.40 | 9,798 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-15 | M | A | 16,670 | $0.00 | 16,670 | D | — | — | (F1) On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. |
| 3 | Derivative | Restricted Stock Unit | 2024-02-15 | M | D | 16,670 | $0.00 | 33,330 | D | $0.00 · — to — | 16,670 Common Stock | (F1) On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. |